Large-scale testing (Phase 3)Study completedNCT00400309What this trial is testingSafety of REPEVAX® Given One Month After REVAXIS®Who this might be right forHealthy Adult Sanofi Pasteur, a Sanofi Company 500
Large-scale testing (Phase 3)Study completedNCT01287949What this trial is testingSafety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or OlderWho this might be right forDiphtheriaTetanusPoliomyelitis+1 more Sanofi Pasteur, a Sanofi Company 342
Testing effectiveness (Phase 2)Study completedNCT01323270What this trial is testingA Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.Who this might be right forMeningococcal VaccinerLP2086Repevax+2 more Pfizer 753
Large-scale testing (Phase 3)Study completedNCT01073293What this trial is testingV503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)Who this might be right forPapillomavirus Infections Merck Sharp & Dohme LLC 1,054
Post-approval studies (Phase 4)Study completedNCT02526394What this trial is testingPertussis and Meningitis C Concomitant Vaccination in AdolescentsWho this might be right forPertussisMeningitisPreventive Immunization; Meningitis+1 more Public Health England 400
Large-scale testing (Phase 3)Study completedNCT01245049What this trial is testingImmunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old ChildrenWho this might be right forAcellular PertussisPoliomyelitisTetanus+1 more GlaxoSmithKline 387
Large-scale testing (Phase 3)Study completedNCT01249183What this trial is testingSafety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldWho this might be right forDiphtheriaTetanusPertussis+1 more Sanofi Pasteur, a Sanofi Company 954
Large-scale testing (Phase 3)Study completedNCT00337428What this trial is testingConcomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)Who this might be right forNeoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more Merck Sharp & Dohme LLC 843